LivaNova PLC (NASDAQ:LIVN) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January 26, ...

Greenlight Capital, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In 2024, the Greenlight Capital funds returned 7.2% ...

The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first ...

The projected fair value for LivaNova is US$89.17 based on 2 Stage Free Cash Flow to Equity LivaNova's US$64.62 share price signals that it might be 28% undervalued Our fair value estimate is 25% ...

While LivaNova PLC (NASDAQ:LIVN) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. With many ...

Good day, ladies and gentlemen, and welcome to the LivaNova PLC Fourth Quarter and Full-Year 2024 Earnings Conference Call. As a reminder, this conference call is being recorded. I'd now like to ...

Investing.com -- KeyBanc Capital Markets has identified three standout performers in the medical technology sector, with ...

Good day, ladies and gentlemen, and welcome to LivaNova plc Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'd now like to ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6, 2025, at 1 ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced it is reiterating its ...

Legal & General Group Plc trimmed its holdings in LivaNova PLC (NASDAQ:LIVN – Free Report) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 113,728 shares of the ...